Recently, dysregulation of P4HA2 has been implicated in various types of cancers, such as oral squamous cell carcinoma [7], breast cancer [8], hepatocellular carcinoma [9], and pancreatic cancer [10]. This evidence concerns the gene P4HA2 and familial pancreatic carcinoma.